ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Chlorthalidone Linked to Higher Risk of Electrolyte, Kidney Problems

Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Thalitone pill

Chlorthalidone — known by the brand name Thalitone — is the American College of Cardiology and American Heart Association’s preferred first-line treatment for high blood pressure, but a recent study found that the drug may cause more serious side effects than similar drugs. 

The February 2020 cohort study by Drs. George Hripcsak, Marc A. Suchard and Steven Shea published in JAMA Internal Medicine looked at medical data from 730,255 people. Researchers compared the safety and effectiveness of chlorthalidone and a similar drug, hydrochlorothiazide.

Chlorthalidone and hydrochlorothiazide are both diuretics — also called “water pills” — and belong to the thiazide-like and thiazide drug classes, respectively. They work to lower blood pressure by causing the kidneys to remove excess water and salt from the body through urine. 

According to the JAMA study, both drugs are just as effective and chlorthalidone doesn’t protect the heart any better than hydrochlorothiazide. But chlorthalidone was associated with a “significantly higher risk” of side effects. 

Chlorthalidone increased the risk of the following side effects when compared to hydrochlorothiazide:

  • Low potassium levels (hypokalemia), nearly three times greater risk
  • Low sodium levels (hyponatremia), 31 percent greater risk
  • Acute kidney failure, 37 percent greater risk
  • Chronic kidney disease, 24 percent greater risk
  • Type 2 diabetes, 21 percent greater risk

“The difference in the occurrence of side effects was striking,” Dr. Hripcsak told Columbia University. “Hypokalemia, hyponatremia, chronic and acute kidney problems, along with other electrolyte imbalances, are all potentially dangerous side effects.”

Researchers say their findings don’t support chlorthalidone as the preferred treatment, but more studies are needed before regulators change guidelines. 

Chlorthalidone Is One of the Oldest Blood Pressure Drugs

Thiazide and thiazide-like drugs have been around since the late 1950s, and health care providers have prescribed them to lower blood pressure for decades. This makes them the oldest type of blood pressure drug on the market. 

About 103 million Americans have high blood pressure, according to the American Heart Association. High blood pressure is a serious condition that can lead to heart attack, stroke, heart failure and other serious diseases. 

Health care providers in the Unites States write about 49 million prescriptions a year for hydrochlorothiazide alone, according to Consumer Reports.  

Thiazide and thiazide-like drugs are also less expensive than other blood pressure medications such as valsartan, losartan and lisinopril — many of these other blood pressure drugs were included in N-nitrosodimethylamine (NDMA) contamination recalls in 2018.

Electrolyte Imbalance and Other Side Effects

The 2020 JAMA study isn’t the first study to find side effects with chlorthalidone, according to Columbia University. Previous studies found that the drug was associated with more electrolyte imbalances than hydrochlorothiazide. 

Electrolyte balance refers to the balance between sodium, calcium, potassium, chloride, phosphate and magnesium in the body. Too little or too much water in the body can cause these levels to become imbalanced and lead to several side effects.

According to the Thalitone drug label, all patients taking chlorthalidone should be observed for clinical signs of electrolyte imbalance, including:

  • Drowsiness
  • Dryness of mouth
  • Gastrointestinal disturbances, such as nausea and vomiting 
  • Lethargy
  • Low blood pressure (hypotension)
  • Low urine output (oliguria)
  • Muscle pains or cramps
  • Muscular fatigue
  • Palpitations
  • Restlessness
  • Tachycardia
  • Thirst
  • Weakness

The label also warns that people with liver problems who take chlorthalidone should use caution. Electrolyte imbalance is particularly dangerous for people with liver problems, because minor electrolyte imbalance can cause hepatic coma — a loss of brain function that happens when the liver doesn’t remove toxins from the blood. 

Other side effects have been reported with chlorthalidone use, but there isn’t enough data for researchers to determine their frequency, according to the drug label. 

Other side effects include:

  • Blood cell irregularities
  • Color vision deficiency (xanthopsia)
  • Cramping
  • Diarrhea
  • Dizziness
  • Frequent urination
  • Gastric irritation
  • Headache
  • Hypoglycemia
  • Impotence
  • Jaundice
  • Low blood pressure aggravated by alcohol, barbiturates or narcotics
  • Muscle spasm
  • Pancreatitis
  • Pins and needles (paresthesia)
  • Rash
  • Restlessness
  • Vertigo
  • Vomiting
  • Weakness

People with moderate or severe side effects may need to adjust their dose or discontinue chlorthalidone, according to the drug label. Patients who experience side effects should speak to their health care providers.

  •  
  •  
  •  
Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for seven years. She specializes in fluoroquinolone antibiotics and products that affect women’s health such as Essure birth control, transvaginal mesh and talcum powder. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • American Medical Writers Association (AMWA) Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine
Edited By

10 Cited Research Articles

Drugwatch.com writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. American Heart Association. (2018, January 31). More than 100 million Americans have high blood pressure, AHA says. Retrieved from https://www.heart.org/en/news/2018/05/01/more-than-100-million-americans-have-high-blood-pressure-aha-says
  2. Columbia University. (n.d.). Recommended Diuretic Causes More Serious Side Effects Than Similar Hypertension Drug, Per Recent OHDSI Study. Retrieved from https://www.dbmi.columbia.edu/ohdsi-chlorthalidone-side-effects-study/
  3. Harrar, Sari. (2017, February 3). Our experts weigh in on these widely used medications. Retrieved from https://www.consumerreports.org/health/diuretics-for-high-blood-pressure/
  4. Hripcsak, G., Suchard, M.A. & Shea, S. (2020, February 17). Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension. Retrieved from https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2760777?resultClick=1
  5. Moser, M. & Feig, P.U. (2009, November 9). Fifty Years of Thiazide Diuretic Therapy for Hypertension. Retrieved from https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1108565
  6. U.S. Food and Drug Administration. (2018). Talitone (chlorthalidone) Tablets USP 15 mg and 25 mg. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019574s016lbl.pdf
  7. U.S. National Library of Medicine. (n.d.). Chlorthalidone. Retrieved from https://medlineplus.gov/druginfo/meds/a682342.html
  8. U.S. National Library of Medicine. (n.d.). Fluid and Electrolyte Balance. Retrieved from https://medlineplus.gov/fluidandelectrolytebalance.html
  9. Whelton, P.K. et al. (2017, November 13). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Retrieved from https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
  10. Image of Thalitone pills. Retrieved from https://pillbox.nlm.nih.gov/assets/large/615700024.jpg
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(888) 645-1617